High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease
- Conditions
- Chronic Kidney Failure
- Registration Number
- NCT03456232
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Brief Summary
This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.
- Detailed Description
Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy.
Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- Subject has end-stage renal disease.
- Subject has been on regular dialysis treatment for at least 6 months.
- Subject has autologous vascular access.
- Subject is offered thrice weekly hemodialysis.
- Subject is offered 4 hours duration hemodialysis.
- Infectious disease
- Poor echocardiographic window that was unsuitable for interpretation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Clearance of moderate molecule substance 4 hours after dialysis Clearance rate of b2-microglobulin for one dialysis.
- Secondary Outcome Measures
Name Time Method Left ventricular ejection fraction 4 hours after dialysis Left ventricular ejection fraction is calculated by dividing the volume of blood pumped from the left ventricle per beat, also known as stroke volume, by the end-diastolic volume.
Trial Locations
- Locations (1)
Guangdong General Hospital
🇨🇳Guangzhou, Guangdong, China
Guangdong General Hospital🇨🇳Guangzhou, Guangdong, Chinawei shi, MD,PhDContact+86-20-8385084913925056339@163.comYi Li, MasterSub InvestigatorShuangxin Liu, MD,PhDSub InvestigatorJianchao Ma, MD,PhDSub InvestigatorLixia Xu, MD,PhDSub InvestigatorYuanhan Chen, MasterSub InvestigatorTing Lin, MD,PhDSub Investigator